{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T01:02:49Z","timestamp":1772672569789,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12325-019-01217-9","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T20:03:42Z","timestamp":1579896222000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Early Stages of Chronic Venous Disease: Medical Treatment Alone or in Addition to Endovenous Treatments"],"prefix":"10.1007","volume":"37","author":[{"given":"Armando","family":"Mansilha","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"issue":"3","key":"1217_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.23736\/S0392-9590.18.03999-8","volume":"37","author":"A Nicolaides","year":"2018","unstructured":"Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part I. Int Angiol. 2018;37(3):181\u2013254.","journal-title":"Int Angiol"},{"issue":"2","key":"1217_CR2","first-page":"105","volume":"31","author":"E Rabe","year":"2012","unstructured":"Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez QF. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31(2):105\u201315.","journal-title":"Int Angiol"},{"issue":"1","key":"1217_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jvsv.2014.09.008","volume":"3","author":"AJ Lee","year":"2015","unstructured":"Lee AJ, Robertson LA, Boghossian SM, et al. Progression of varicose veins and chronic venous insufficiency in the general population in the Edinburgh Vein Study. J Vasc Surg Venous Lymphat Disord. 2015;3(1):18\u201326.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"6","key":"1217_CR4","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3390\/ijms19061669","volume":"19","author":"A Mansilha","year":"2018","unstructured":"Mansilha A, Sousa J. Pathophysiological mechanisms of chronic venous disease and implications for venoactive drug therapy. Int J Mol Sci. 2018;19(6):1669.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1217_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.23736\/S0392-9590.18.03901-9","volume":"37","author":"M Lugli","year":"2018","unstructured":"Lugli M, Maleti O, Iabichella ML, Perrin M. Investigation of non-saphenous veins in C0S patients. Int Angiol. 2018;37(2):169\u201375.","journal-title":"Int Angiol"},{"issue":"2","key":"1217_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.23736\/S0392-9590.18.03975-5","volume":"37","author":"SK Kakkos","year":"2018","unstructured":"Kakkos SK, Nicolaides AN. Efficacy of micronized purified flavonoid fraction (Daflon\u00ae) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials. Int Angiol. 2018;37(2):143\u201354.","journal-title":"Int Angiol"},{"issue":"1","key":"1217_CR7","first-page":"3","volume":"22","author":"YT Tsoukanov","year":"2017","unstructured":"Tsoukanov YT, Tsoukanov AY, Nikoiaychuk A. Great saphenous vein transitory reflux in patients with symptoms related to chronic venous disorders, but without visible signs (C0s), and its correction with MPFF treatment. Phlebolymphology. 2017;22(1):3\u201311.","journal-title":"Phlebolymphology"},{"issue":"2","key":"1217_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.23736\/S0392-9590.16.03708-1","volume":"36","author":"YT Tsukanov","year":"2017","unstructured":"Tsukanov YT, Nikolaichuk AI. Orthostatic-loading-induced transient venous refluxes (day orthostatic loading test), and remedial effect of micronized purified flavonoid fraction in patients with telangiectasia and reticular vein. Int Angiol. 2017;36(2):189\u201396.","journal-title":"Int Angiol"},{"issue":"3","key":"1217_CR9","first-page":"144","volume":"24","author":"YT Tsukanov","year":"2017","unstructured":"Tsukanov YT, Tsukanov AY. Diagnosis and treatment of situational great saphenous vein reflux in daily medical practice. Phlebolymphology. 2017;24(3):144\u201351.","journal-title":"Phlebolymphology"},{"issue":"4","key":"1217_CR10","first-page":"181","volume":"20","author":"VY Bogachev","year":"2013","unstructured":"Bogachev VY, Golovanova OV, Kuzhetsov AN, Shekoian AO, the DECISION Investigators group. Can micronized purified flavonoid fraction* (MPFF) improve outcomes of lower extremity varicose vein endovenous treatment? First results from the DECISION study. Phlebolymphology. 2013;20(4):181\u20137.","journal-title":"Phlebolymphology"},{"issue":"7","key":"1217_CR11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s12325-018-0731-z","volume":"35","author":"VY Bogachev","year":"2018","unstructured":"Bogachev VY, Boldin BV, Turkin PY. Administration of micronized purified flavonoid fraction during sclerotherapy of reticular veins and telangiectasias: results of the national, multicenter, observational Program VEIN ACT PROLONGED-C1. Adv Ther. 2018;35(7):1001\u20138.","journal-title":"Adv Ther"},{"issue":"1","key":"1217_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.23736\/S0392-9590.17.03868-8","volume":"37","author":"VY Bogachev","year":"2018","unstructured":"Bogachev VY, Boldin BV, Lobanov VN. Benefits of micronized purified flavonoid fraction as adjuvant therapy on inflammatory response after sclerotherapy. Int Angiol. 2018;37(1):71\u20138.","journal-title":"Int Angiol"},{"issue":"6","key":"1217_CR13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ejvs.2015.02.007","volume":"49","author":"C Wittens","year":"2015","unstructured":"Wittens C, Davies AH, Baekgaard N, et al. Editor\u2019s choice\u2014management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015;49(6):678\u2013737.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1217_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.23736\/S0392-9590.19.04216-0","volume":"38","author":"A Mansilha","year":"2019","unstructured":"Mansilha A, Sousa J. Benefits of venoactive drug therapy in surgical or endovenous treatment for varicose veins: a systematic review. Int Angiol. 2019;38:291\u20138.","journal-title":"Int Angiol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01217-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-019-01217-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01217-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T09:23:11Z","timestamp":1713172991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-019-01217-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":14,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1217"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-01217-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]},"assertion":[{"value":"26 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}